Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christie Freeman"'
Autor:
Suzanne Murray, Jeffrey Crowley, Melinda J. Gooderham, Alan Kivitz, Vinod Chandran, Sophie Péloquin, Paul P. Doghramji, Christie Freeman, Patrice Lazure
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 7:35-43
Background The paradigm shift toward biologic medications in psoriasis care requires healthcare providers (HCPs) to become acquainted with mechanisms of action and safety profiles of these new treatments to confidently use them in practice. A better
Autor:
Sacha Zahabi, Melinda Gooderham, Paul P. Doghramji, Suzanne Murray, Vinod Chandran, Jeffrey J. Crowley, Patrice Lazure, Alan Kivitz, Christie Freeman
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB4
Autor:
Matts Kågedal, Whitney P. Kirschbrown, José Bines, Debora Fumagalli, Guy Jerusalem, Christie Freeman, Ihsan Nijem, Adam Knott, Amit Garg, Bei Wang, Lars Lindbom, Rachelle Mack, Gunter von Minckwitz, Sandhya Girish, Chris Twelves, José Baselga, Sharareh Monemi, Robin McConnell
Publikováno v:
Cancer chemotherapy and pharmacology, 83 (6
Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology
Purpose: To characterize the pharmacokinetics (PK) of, and perform an exploratory exposure–response (E–R) analysis for, pertuzumab in patients with HER2-positive early breast cancer (EBC) within the APHINITY study (NCT01358877, BIG 4–11/BO25126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf041279549839c28ce3b5887fdd4396
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290293
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290293
Autor:
Richard D. Gelber, Debora Fumagalli, Martine Piccart, Anh Nguyen Duc, Giuseppe Viale, Fergus Daly, Vanessa Honvault, Otto Metzger, Andrew Bailey, Heather L. McArthur, Eric S. Winer, Christie Freeman, Sebastian Guillaume, Valeria Karusinova, Catherine Lai, Jorge Luis Martinez, Mariana Brandão, Carter Dufrane, Aicha Bouhlel, Michail Ignatiadis
Publikováno v:
Journal of Clinical Oncology. 37:TPS598-TPS598
TPS598 Background: Early stage triple negative breast cancer (TNBC) is associated with a high risk of distant relapse. Because TNBC does not currently have specific targeted agents approved for use in the early setting it is treated primarily with ch